AllianceBernstein
TARS icon

AllianceBernstein’s Tarsus Pharmaceuticals TARS Stock Holding History

AllianceBernstein’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.58M Buy
51,029
+10,413
+26% +$665K ﹤0.01% 1739
2026
Q1 		$3.33M Sell
40,616
-38
-0.1% -$2.65K ﹤0.01% 1731
2025
Q4 		$3.33M Sell
40,654
-300
-0.7% -$22.4K ﹤0.01% 1738
2025
Q3 		$2.43M Buy
40,954
+1,900
+5% +$93.5K ﹤0.01% 1891
2025
Q2 		$1.58M Hold
39,054
– – ﹤0.01% 2052
2025
Q1 		$2.01M Buy
39,054
+804
+2% +$39.7K ﹤0.01% 1898
2024
Q4 		$2.12M Hold
38,250
– – ﹤0.01% 1930
2024
Q3 		$1.26M Buy
38,250
+3,130
+9% +$88K ﹤0.01% 2204
2024
Q2 		$955K Buy
35,120
+7,820
+29% +$263K ﹤0.01% 2330
2024
Q1 		$992K Buy
27,300
+6,640
+32% +$195K ﹤0.01% 2270
2023
Q4 		$418K Sell
20,660
-85,000
-80% -$1.42M ﹤0.01% 2698
2023
Q3 		$1.88M Buy
105,660
+85,000
+411% +$1.5M ﹤0.01% 1916
2023
Q2 		$373K Buy
+20,660
New +$328K ﹤0.01% 2774

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AllianceBernstein's TARS Position: Q2 2026 in Review

AllianceBernstein increased its Tarsus Pharmaceuticals (TARS) stake by 26% in Q2 2026, buying an estimated $665K and bringing the position to 51,029 shares worth $3.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

AllianceBernstein first reported a position in TARS in Q2 2023 and has held it in 13 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • AllianceBernstein held 51,029 shares of Tarsus Pharmaceuticals worth $3.58M as of Q2 2026.
  • AllianceBernstein bought 10,413 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $665K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1739 holding.
  • AllianceBernstein first reported a position in Tarsus Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.